BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2869850)

  • 1. Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man.
    Jones CR; Giembcyz M; Hamilton CA; Rodger IW; Whyte K; Deighton N; Elliott HL; Reid JL
    Clin Sci (Lond); 1986 Feb; 70(2):147-53. PubMed ID: 2869850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues.
    Larsson PT; Martinsson A; Olsson G; Hjemdahl P
    Br J Clin Pharmacol; 1989 Dec; 28(6):663-74. PubMed ID: 2558700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and reversible desensitisation of vascular and platelet alpha 2 adrenoceptors.
    Hamilton CA; Deighton NM; Reid JL
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):534-40. PubMed ID: 2886922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic regulation of alpha 2-adrenoceptor number and function in man.
    Jones CR; Hamilton CA; Whyte KF; Elliott HL; Reid JL
    Clin Sci (Lond); 1985; 68 Suppl 10():129s-132s. PubMed ID: 2857608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of alpha 2-adrenoceptor desensitization induced by adrenaline infusion in man.
    Lübbecke F; Zschätzsch S; Mitrovic V; Husseini H; Schütterle G; Wizemann V
    Pharmacology; 1990; 40(4):231-5. PubMed ID: 2167486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of dog platelet alpha-adrenergic receptor: lack of in vivo down regulation by adrenergic agonist treatments.
    Villeneuve A; Berlan M; Lafontan M; Montastruc JL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 81(1):181-7. PubMed ID: 2861047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on alpha 2-adrenoceptors in rabbits with perinephritis hypertension.
    Hamilton CA; Reid JL; Jones CR
    J Hypertens; 1986 Feb; 4(1):77-83. PubMed ID: 2870119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization of vascular and platelet alpha 2-adrenoceptors in rabbits with perinephritis hypertension.
    Hamilton CA; Howie CA; Reid JL
    J Hypertens; 1988 Apr; 6(4):277-82. PubMed ID: 2897989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets.
    Grant JA; Scrutton MC
    Br J Pharmacol; 1980; 71(1):121-34. PubMed ID: 6110451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog.
    Estan L; Senard JM; Tran MA; Montastruc JL; Berlan M
    Br J Pharmacol; 1990 Oct; 101(2):329-36. PubMed ID: 2175232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets.
    Swart SS; Maguire M; Wood JK; Barnett DB
    Eur J Pharmacol; 1985 Oct; 116(1-2):113-9. PubMed ID: 2996911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-Methylated and sulfoconjugated catecholamines: differential activities at human platelet alpha 2-adrenoceptors.
    Lenz T; Werle E; Strobel G; Weicker H
    Can J Physiol Pharmacol; 1991 Jul; 69(7):929-37. PubMed ID: 1683267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
    Clare KA; Scrutton MC; Thompson NT
    Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labelling of human platelet alpha 2-adrenoceptors with the full agonist [3H](-)adrenaline.
    Garcia-Sevilla JA; Fuster MJ
    Eur J Pharmacol; 1986 May; 124(1-2):31-41. PubMed ID: 3013661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivo.
    Galinier M; Senard JM; Valet P; Boneu B; Galinier F; Montastruc JL
    Arch Int Pharmacodyn Ther; 1989; 301():30-9. PubMed ID: 2576196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines.
    Hollister AS; FitzGerald GA; Nadeau JH; Robertson D
    J Clin Invest; 1983 Oct; 72(4):1498-505. PubMed ID: 6138365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian platelet adrenoceptors.
    Kerry R; Scrutton MC; Wallis RB
    Br J Pharmacol; 1984 Jan; 81(1):91-102. PubMed ID: 6322894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet beta-adrenoceptors.
    Kerry R; Scrutton MC
    Br J Pharmacol; 1983 Jul; 79(3):681-91. PubMed ID: 6140045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
    Brodde OE; Daul A; O'Hara N; Bock KD
    J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.